Biotech

All Articles

Sanofi's $80M bank on Pivot dystrophy medicine finishes in period 3 go belly up

.Simply 4 months after Sanofi wager $80 thousand in ahead of time cash money on Pivot Therapeutics' ...

Oncternal assets drains 60% amidst unemployments, test firings

.Cancer cells firm Oncternal Therapies is actually folding all its clinical tests and also laying of...

Roche is holding out hopes that its injectable obesity possibility can ultimately show 25% weight loss in late-stage test

.Roche is actually keeping out hopes that its injectable weight problems possibility could inevitabl...

Novo Nordisk barrages 'impressive' weight-loss result for dual-acting dental drug in early test

.Novo Nordisk has actually raised the cover on a stage 1 test of its own oral amylin as well as GLP-...

AbbVie files suit BeiGene over blood cancer cells medication classified information

.Only a handful of short weeks after succeeding an FDA Fast lane tag for its investigational BTK deg...

Lilly delivers one-two punch with second tranche of favorable data on once a week insulin candidate

.Shortly after a favorable data drop for Eli Lilly's efsitora alfa, the Indianapolis-based company i...

BridgeBio cuts genetics treatment spending plan as scientific information disappoint

.BridgeBio Pharma is lowering its own gene treatment finances as well as pulling back from the metho...

GSK surrenders HSV vaccination hopes after period 2 fall short, ceding race to Moderna, BioNTech

.GSK's attempt to create the initial injection for herpes simplex virus (HSV) has finished in breakd...

GSK's long-acting asthma medicine cut in half strikes in phase 3

.GSK's long-acting bronchial asthma procedure has been actually shown to cut in half the number of a...

AstraZeneca, Daiichi unpack Dato-DXd's general survival fail

.AstraZeneca and also Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has fallen short...